Priftin (Page 7 of 7)

rifapentine

Label ImageLabel Image
PRIFTIN rifapentine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50090-5063(NDC:0088-2102)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RIFAPENTINE (RIFAPENTINE) RIFAPENTINE 150 mg
Inactive Ingredients
Ingredient Name Strength
CALCIUM STEARATE
EDETATE DISODIUM
FD&C BLUE NO. 2
ALUMINUM OXIDE
HYDROXYPROPYL CELLULOSE (1600000 WAMW)
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
POLYETHYLENE GLYCOL, UNSPECIFIED
STARCH, CORN
PROPYLENE GLYCOL
SODIUM ASCORBATE
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A CORN
FERRIC OXIDE RED
TITANIUM DIOXIDE
Product Characteristics
Color PINK (dark pink) Score no score
Shape ROUND Size 10mm
Flavor Imprint Code F
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50090-5063-0 3 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 8 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (50090-5063-0)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021024 02/08/2017
Labeler — A-S Medication Solutions (830016429)
Establishment
Name Address ID/FEI Operations
A-S Medication Solutions 830016429 RELABEL (50090-5063)

Revised: 05/2022 A-S Medication Solutions

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.